Anatara Lifesciences LtdASX: ANR

Investor Presentation and Strategy Update

· Issued by Anatara Lifesciences Ltd

Filed with ASX · · 24 pages · English

BRISBANE, 18th July 2018: Anatara Lifesciences (ASX:ANR) is pleased to release its latest presentation and strategy update that will be delivered to institutional investors this week. In outlining its future strategy, Anatara has provided an update on its efforts to develop its product pipeline, extending from its core application to control diarrhoea in pigs, to the management of human gastrointe

Anatara Lifesciences Ltd on 6ix

In the deck

Earlier from Anatara Lifesciences

Later from Anatara Lifesciences

All Anatara Lifesciences news releases